Livforsakringsbolaget Skandia Omsesidigt Has $20.32 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Livforsakringsbolaget Skandia Omsesidigt raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 441.9% during the 4th quarter, Holdings Channel reports. The institutional investor owned 40,162 shares of the healthcare conglomerate’s stock after purchasing an additional 32,750 shares during the quarter. UnitedHealth Group makes up 1.1% of Livforsakringsbolaget Skandia Omsesidigt’s holdings, making the stock its 11th largest position. Livforsakringsbolaget Skandia Omsesidigt’s holdings in UnitedHealth Group were worth $20,316,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the stock. Kathleen S. Wright Associates Inc. bought a new stake in shares of UnitedHealth Group during the 3rd quarter worth $27,000. AlphaMark Advisors LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth $30,000. West Financial Advisors LLC bought a new stake in shares of UnitedHealth Group during the 3rd quarter worth $32,000. RPg Family Wealth Advisory LLC bought a new stake in shares of UnitedHealth Group during the 3rd quarter worth $37,000. Finally, Friedenthal Financial bought a new stake in UnitedHealth Group in the 3rd quarter valued at $51,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the stock. Piper Sandler reduced their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. Royal Bank of Canada reduced their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a report on Wednesday, October 16th. Morgan Stanley dropped their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. KeyCorp reiterated an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Deutsche Bank Aktiengesellschaft increased their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Buy” and a consensus target price of $629.32.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $529.71 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a market capitalization of $487.48 billion, a P/E ratio of 34.17, a price-to-earnings-growth ratio of 1.48 and a beta of 0.61. The company’s 50 day moving average price is $532.43 and its two-hundred day moving average price is $564.77.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period last year, the company earned $5.83 earnings per share. The firm’s revenue was up 6.8% compared to the same quarter last year. On average, analysts expect that UnitedHealth Group Incorporated will post 29.63 earnings per share for the current fiscal year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.